# Oxaliplatin in Gastric Cancer

> **NCT00263354** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 20 (—)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00263354
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 20 (—)
- **Last updated:** 2010-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263354, "Oxaliplatin in Gastric Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00263354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*